RE:RE:RE:RE:Concordiabencro wrote: Funny ... Our clown seems to defend vigorously his boss. ... ;-) ... Concordia should have planned better their trial. ... Bunch of amateur, when you read that they cannot recruit enough patients for their indication. ... Why having invested so much ... to end up with a clinical trial that could deliver non-statistically data. Or non-conving one because of a too small sample of patients!!!! ... Contrary to Concordia, TLT is able to target with its PDC, cancers that are among the most difficult to treat and that involve a large pool of patients ... Melanoma is the fastest growing cancer, Lung is #1 killer in both US and Canada, bladder is the most recurring cancer. ... And our clown sits here trying to make us believe that Photofrin is Superior to TLD-1433 ... Even in pre-clinical model, Photofrin never delivered Superior data than TLD-1433 ... Our clown is unable to provide data that shows the contrary ... No Wonder why he keeps posting here only with bla-bla-bla posts.
When Therelase PDC shows it's safe and effective, what would be the point in even making Photofrin?